Search filters

List of works by Chiara Tarantelli

Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphoma

scientific article published on 03 August 2018

Bromodomain inhibitor OTX015 (MK-8628) combined with targeted agents shows strong in vivo antitumor activity in lymphoma.

scientific article published on August 2016

DNA Damage Response Inhibitor Combinations Exert Synergistic Antitumor Activity in Aggressive B-Cell Lymphomas

scientific article published on 07 May 2019

In vitro demonstration of synergism with pixantrone combined with targeted agents in lymphomas

scientific article published on 19 December 2018

PQR309 Is a Novel Dual PI3K/mTOR Inhibitor with Preclinical Antitumor Activity in Lymphomas as a Single Agent and in Combination Therapy.

scientific article

Preclinical evaluation of the BET bromodomain inhibitor BAY 1238097 for the treatment of lymphoma.

scientific article published on 27 June 2017

Single and combined BTK and PI3Kδ inhibition with acalabrutinib and ACP-319 in pre-clinical models of aggressive lymphomas

scientific article published on 29 July 2019

The BET Bromodomain Inhibitor OTX015 Affects Pathogenetic Pathways in Preclinical B-cell Tumor Models and Synergizes with Targeted Drugs.

scientific article

The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents

scientific article published on 10 June 2019

The Novel TORC1/2 Kinase Inhibitor PQR620 Has Anti-Tumor Activity in Lymphomas as a Single Agent and in Combination with Venetoclax

scientific article published on 04 June 2019

The novel atypical retinoid ST5589 down-regulates Aurora Kinase A and has anti-tumour activity in lymphoma pre-clinical models.

scientific article published on 3 August 2015

Paulina is supported by:

About Paulina

Help